Diabetes und herztransplantation

Translated title of the contribution: Diabetes and heart transplantation

Matthias Loebe, K. Ramasubbu, Dale J. Hamilton

Research output: Contribution to journalReview articlepeer-review


Diabetes is frequently encountered in patients presenting with end-stage heart failure to be listed for transplantation. While diabetes used to be a contra-indication for heart transplantation, careful preoperative evaluation and individualized postoperative medication lead to long-term outcome after heart transplantation equal to non-diabetic patients. About 1/3 of transplanted patients develop a posttransplant diabetes. Several risk factors have been identified leading to this condition. Mostly, posttransplant diabetes is of temporary nature. Several studies have shown no impact of diabetes on the incidence of rejection, malignancies, and transplant vasculopathy. However, glucose intolerance must be taken into consideration when planing immunosuppressive therapy since different medications have distinct impact on glucose metabolism after transplant. A multidisciplinary team allows for closely monitoring and treating patients with diabetes after heart transplant.

Translated title of the contributionDiabetes and heart transplantation
Original languageGerman
JournalClinical Research in Cardiology
Issue number1 SUPPL.
StatePublished - Jan 1 2006


  • Diabetes mellitus
  • Heart transplant
  • Immunosuppression
  • Insulin

ASJC Scopus subject areas

  • Mechanics of Materials
  • Computational Mechanics


Dive into the research topics of 'Diabetes and heart transplantation'. Together they form a unique fingerprint.

Cite this